my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Non-specific adsorption (NSA) of metal sensitive analytes can lead to loss of sensitivity, poor peak shape, poor reproducibility and lengthy passivation procedures. The occurrence of these NSA losses can be hard to predict and therefore, a good plan to mitigate them leads to less risk and more confidence in analytical results.
ACQUITY PREMIER Columns feature MaxPeak High Performance Surfaces, innovative technologies designed to increase analyte recovery, sensitivity and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
ACQUITY PREMIER columns increase sensitivity, repeatability and confidence in analytical results ultimately leading to time savings, improved productivity and better decision making.
Performance you need, Results you can trust
Rugged and reliable HPLC designed for quality control Seamless transfer without changing your method Improve your productivity and efficiency more
Revolutionize Your Research with the Waters SELECT SERIES Cyclic IMS
Combines novel cyclic ion mobility separation with superior time-of-flight mass spectrometry ✓ Trennen Sie mit ultimativer Auflösung in der Ionenmobilität mehr als jemals zuvor für absolute Sicherheit more
Performance you need, Results you can trust
Ever-evolving regulations are impacting LC method approaches for product quality control and beyond. Count on the Arc HPLC System for high-efficiency separations and quality data to help meet your regulatory requirements with confidence. Arc HPLC allows you to easily replicate and improve t ... more
Did you know that metal interactions can put your analytical results at RISK?
Non-specific adsorption (NSA) of metal sensitive analytes can lead to loss of sensitivity, poor peak shape, poor reproducibility and lengthy passivation procedures. The occurrence of these NSA losses can be hard to predict and therefore, a good plan to mitigate them leads to less risk and ... more
Waters Corporation Appoints Pearl S. Huang to Board of Directors
Waters Corporation announced that Dr. Pearl S. Huang, President and CEO of Cygnal Therapeutics and venture partner at Flagship Pioneering, has been appointed as a Director of Waters Corporation, effective January 1, 2021. “We are pleased to welcome Pearl to the Waters Board of Directors,” ... more
Waters Corporation has formally expanded its long-standing, collaborative relationship with Dr. Sunghwan Kim of Kyungpook National University to further explore the use of Waters’ cutting-edge ion mobility spectrometry (IMS) in the investigation of compounds in complex mixtures. Identifying ... more
Waters Corporation Names Udit Batra President and Chief Executive Officer
Waters Corporation announced that Udit Batra, Ph.D. has been named the Company’s President and Chief Executive Officer, effective September 1, 2020. He will also join Waters’ Board of Directors at that time. Dr. Batra succeeds Christopher O’Connell who will remain in his current roles as Pr ... more
Waters Corporation is a global leader in liquid chromatography (UPLC/HPLC), mass spectrometry (MS), rheology and thermal analysis. The business areas range from research & development, the manufacture and sale of analytical instruments, laboratory software products, column and sample prepar ... more
Waters Corporation creates business advantage for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide. Pioneering a c ... more
Since 1958 Waters offers complete solutions in High Performance Liquid Chromatography (HPLC). With our products and services we set the standards in HPLC. Waters Corporation is a multinational, publicly traded (NYSE: WAT) company headquartered in Milford, Massachusetts, USA. The company ha ... more
